Literature DB >> 27184745

The eNOS signalosome and its link to endothelial dysfunction.

Mauro Siragusa1, Ingrid Fleming2.   

Abstract

Endothelial nitric oxide synthase (eNOS) plays an essential role in the regulation of endothelial function and acts as a master regulator of vascular tone and homeostasis through the generation of the gasotransmitter nitric oxide (NO). The complex network of events mediating efficient NO synthesis is regulated by post-translational modifications and protein-protein interactions. Dysregulation of these mechanisms induces endothelial dysfunction, a term often used to refer to reduced NO bioavailability and consequent alterations in endothelial function, that are a hallmark of many cardiovascular diseases. Endothelial dysfunction is linked to eNOS uncoupling, which consists of a switch from the generation of NO to the generation of superoxide anions and hydrogen peroxide. This review provides an overview of the eNOS signalosome, integrating past and recently described protein-protein interactions that have been shown to play a role in the modulation of eNOS activity with implications for cardiovascular pathophysiology. The mechanisms underlying eNOS uncoupling and clinically relevant strategies that were adopted to influence them are also discussed.

Entities:  

Keywords:  Endothelial dysfunction; Endothelial nitric oxide synthase; Endothelium; Signalosome; Uncoupling

Mesh:

Substances:

Year:  2016        PMID: 27184745     DOI: 10.1007/s00424-016-1839-0

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  123 in total

1.  NOSIP, a novel modulator of endothelial nitric oxide synthase activity.

Authors:  J Dedio; P König; P Wohlfart; C Schroeder; W Kummer; W Müller-Esterl
Journal:  FASEB J       Date:  2001-01       Impact factor: 5.191

2.  Cell cycle-regulated inactivation of endothelial NO synthase through NOSIP-dependent targeting to the cytoskeleton.

Authors:  Michael Schleicher; Fredrik Brundin; Steffen Gross; Werner Müller-Esterl; Stefanie Oess
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

3.  Localization of endothelial nitric-oxide synthase phosphorylated on serine 1179 and nitric oxide in Golgi and plasma membrane defines the existence of two pools of active enzyme.

Authors:  David Fulton; Jason Fontana; Grzegorz Sowa; Jean-Philippe Gratton; Michelle Lin; Kai-Xun Li; Belinda Michell; Bruce E Kemp; David Rodman; William C Sessa
Journal:  J Biol Chem       Date:  2001-11-29       Impact factor: 5.157

4.  Elevated blood pressures in mice lacking endothelial nitric oxide synthase.

Authors:  E G Shesely; N Maeda; H S Kim; K M Desai; J H Krege; V E Laubach; P A Sherman; W C Sessa; O Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

5.  AMP-activated protein kinase (AMPK) regulates the insulin-induced activation of the nitric oxide synthase in human platelets.

Authors:  Ingrid Fleming; Christian Schulz; Birgit Fichtlscherer; Bruce E Kemp; Beate Fisslthaler; Rudi Busse
Journal:  Thromb Haemost       Date:  2003-11       Impact factor: 5.249

Review 6.  Life history of eNOS: partners and pathways.

Authors:  David M Dudzinski; Thomas Michel
Journal:  Cardiovasc Res       Date:  2007-04-03       Impact factor: 10.787

7.  Functional relevance of Golgi- and plasma membrane-localized endothelial NO synthase in reconstituted endothelial cells.

Authors:  Qian Zhang; Jarrod E Church; Davin Jagnandan; John D Catravas; William C Sessa; David Fulton
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-03-02       Impact factor: 8.311

8.  Stromal cell derived factor-2 (Sdf2): a novel protein expressed in mouse.

Authors:  Aline R Lorenzon-Ojea; Waldir Caldeira; Alberto F Ribeiro; Susan J Fisher; Cristiane R Guzzo; Estela Bevilacqua
Journal:  Int J Biochem Cell Biol       Date:  2014-05-28       Impact factor: 5.085

9.  Increased endothelial tetrahydrobiopterin synthesis by targeted transgenic GTP-cyclohydrolase I overexpression reduces endothelial dysfunction and atherosclerosis in ApoE-knockout mice.

Authors:  Nicholas J Alp; Martina A McAteer; Jeffrey Khoo; Robin P Choudhury; Keith M Channon
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-01-05       Impact factor: 8.311

10.  Endothelial arginase II: a novel target for the treatment of atherosclerosis.

Authors:  Sungwoo Ryoo; Gaurav Gupta; Alexandre Benjo; Hyun Kyo Lim; Andre Camara; Gautam Sikka; Hyun Kyung Lim; Jayson Sohi; Lakshmi Santhanam; Kevin Soucy; Eric Tuday; Ezra Baraban; Monica Ilies; Gary Gerstenblith; Daniel Nyhan; Artin Shoukas; David W Christianson; Nicholas J Alp; Hunter C Champion; David Huso; Dan E Berkowitz
Journal:  Circ Res       Date:  2008-02-28       Impact factor: 17.367

View more
  41 in total

Review 1.  Contemporary Approaches to Modulating the Nitric Oxide-cGMP Pathway in Cardiovascular Disease.

Authors:  Jan R Kraehling; William C Sessa
Journal:  Circ Res       Date:  2017-03-31       Impact factor: 17.367

Review 2.  Role of folic acid in nitric oxide bioavailability and vascular endothelial function.

Authors:  Anna E Stanhewicz; W Larry Kenney
Journal:  Nutr Rev       Date:  2017-01       Impact factor: 7.110

Review 3.  Reactive species-induced microvascular dysfunction in ischemia/reperfusion.

Authors:  Hong Yu; Ted Kalogeris; Ronald J Korthuis
Journal:  Free Radic Biol Med       Date:  2019-03-05       Impact factor: 7.376

4.  PPARδ agonist prevents endothelial dysfunction via induction of dihydrofolate reductase gene and activation of tetrahydrobiopterin salvage pathway.

Authors:  Zihui Zhang; Xinya Xie; Qinyu Yao; Jia Liu; Ying Tian; Chunmiao Yang; Lei Xiao; Nanping Wang
Journal:  Br J Pharmacol       Date:  2019-07-06       Impact factor: 8.739

5.  The role of vascular endothelial protein tyrosine phosphatase on nitric oxide synthase function in diabetes: from molecular biology to the clinic.

Authors:  Alberto Fernando Oliveira Justo; Pedro Paulo Luciano Afonso
Journal:  J Cell Commun Signal       Date:  2021-03-08       Impact factor: 5.782

6.  Nitric oxide maintains endothelial redox homeostasis through PKM2 inhibition.

Authors:  Mauro Siragusa; Janina Thöle; Sofia-Iris Bibli; Bert Luck; Annemarieke E Loot; Kevin de Silva; Ilka Wittig; Juliana Heidler; Heike Stingl; Voahanginirina Randriamboavonjy; Karin Kohlstedt; Bernhard Brüne; Andreas Weigert; Beate Fisslthaler; Ingrid Fleming
Journal:  EMBO J       Date:  2019-07-22       Impact factor: 11.598

7.  Three-dimensional Printed Mg-Doped β-TCP Bone Tissue Engineering Scaffolds: Effects of Magnesium Ion Concentration on Osteogenesis and Angiogenesis In Vitro.

Authors:  Yifan Gu; Jing Zhang; Xinzhi Zhang; Guiping Liang; Tao Xu; Wei Niu
Journal:  Tissue Eng Regen Med       Date:  2019-06-17       Impact factor: 4.169

8.  Unbiased proteomics identifies plasminogen activator inhibitor-1 as a negative regulator of endothelial nitric oxide synthase.

Authors:  Victor Garcia; Eon Joo Park; Mauro Siragusa; Florian Frohlich; Mohammad Mahfuzul Haque; Jonathan V Pascale; Katherine R Heberlein; Brant E Isakson; Dennis J Stuehr; William C Sessa
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-16       Impact factor: 11.205

9.  Aldose reductase inhibitor, fidarestat prevents doxorubicin-induced endothelial cell death and dysfunction.

Authors:  Himangshu Sonowal; Pabitra Pal; Kirtikar Shukla; Ashish Saxena; Satish K Srivastava; Kota V Ramana
Journal:  Biochem Pharmacol       Date:  2018-02-16       Impact factor: 5.858

Review 10.  Endothelial NOS: perspective and recent developments.

Authors:  Victor Garcia; William C Sessa
Journal:  Br J Pharmacol       Date:  2018-12-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.